Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arich Enterprise CoROCO:4173 -0.57%70 Debt-to-EBITDA is 2.36 as of Jun. 2026, which is 24% below its 10-year median of 3.09. GuruFocus rates ROCO:4173 with a GF Score™ of 70/100 and a GF Value™ of NT$27.99 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 479 Healthcare Providers & Services companies, Arich Enterprise Co ranks worse than 54.7% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Arich Enterprise Co's Debt-to-EBITDA or its related term are showing as below:
ROCO:4173'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.51 Med: 3.09 Max: 47.72
Current: 2.52
During the past 13 years, the highest Debt-to-EBITDA Ratio of Arich Enterprise Co was 47.72. The lowest was 0.51. And the median was 3.09.
ROCO:4173's Debt-to-EBITDA is ranked worse than 54.7% of 479
companies
in the Healthcare Providers & Services industry
Industry Median: 2.19
vs ROCO:4173: 2.52
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Arich Enterprise Co Debt-to-EBITDA Related Terms
Arich Enterprise Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Arich Enterprise Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arich Enterprise Co Debt-to-EBITDA Competitor Comparison
For the Pharmaceutical Retailers subindustry, Arich Enterprise Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arich Enterprise Co Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Arich Enterprise Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Arich Enterprise Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Arich Enterprise Co (ROCO:4173) has a Debt-to-EBITDA of 2.36 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Arich Enterprise Co. This is 24% below median its historical median of 3.09. Over the past decade, Arich Enterprise Co's Debt-to-EBITDA has ranged from 0.51 to 47.72. According to the industry distribution chart, Arich Enterprise Co ranks #262 out of 479 companies in the Healthcare Providers & Services industry, placing it in the top 54.7%.
Is Arich Enterprise Co's Debt-to-EBITDA too high?
Arich Enterprise Co's current Debt-to-EBITDA of 2.36 is 24% below median its 10-year median of 3.09. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 47.72. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. Arich Enterprise Co's value of 2.36 is 7.8% above this industry median. Based on the distribution chart, Arich Enterprise Co ranks #262 out of 479 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Arich Enterprise Co has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arich Enterprise Co's Debt-to-EBITDA compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Arich Enterprise Co ranks #262 out of 479 companies for Debt-to-EBITDA. This places Arich Enterprise Co in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. Arich Enterprise Co's value of 2.36 is 7.8% above this benchmark. Historically, Arich Enterprise Co's own Debt-to-EBITDA has ranged from 0.51 to 47.72 over the past decade. While the company's 10-year median is 3.09 vs. the industry median of 2.19, Arich Enterprise Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 479 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arich Enterprise Co's current Debt-to-EBITDA of 2.36 is 7.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Arich Enterprise Co. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arich Enterprise Co's current Debt-to-EBITDA is 2.36, which is 24% below median its own 10-year median of 3.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arich Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Arich Enterprise Co (ROCO:4173) is currently considered Possible Value Trap. The stock's GF Value™ is NT$27.99, compared to a current price of NT$17.30 — trading 38.2% below its estimated fair value. The current Debt-to-EBITDA is 2.36, which is 24% below median its 10-year median of 3.09 and 7.8% above the Healthcare Providers & Services industry median of 2.19. Arich Enterprise Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Arich Enterprise Co (ROCO:4173), the current Debt-to-EBITDA is 2.36 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arich Enterprise Co (ROCO:4173) Overvalued in 2026?
Based on GuruFocus' analysis, Arich Enterprise Co stock appears to be undervalued.
The current stock price of NT$17.30 is trading 38.2% below its estimated GF Value™ of NT$27.99.
GuruFocus considers Arich Enterprise Co to be Possible Value Trap.
Key valuation signals for ROCO:4173:
Debt-to-EBITDA: 2.36 (24% below median its 10-year median of 3.09)
GF Value™: NT$27.99 vs. price of NT$17.30 (38.2% below fair value)
Industry Position: 7.8% above the Healthcare Providers & Services median (#262 of 479)
No single metric tells the full story. See the ROCO:4173 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arich Enterprise Co Ltd is a Taiwan-based company operating in the pharmaceutical industry. The company is engaged in providing medical sales promotion and logistics services. The company markets and sells pharmaceutical products. The company's services cover customers including medical centers, area hospitals, district hospitals, general practitioners, and key accounts which include chain stores and hypermarkets, drug stores, and wholesalers. The product portfolio includes Actos, Aftach, Cytotec, Gaster, Prometin, Hicee, Lederscon, Alinamin, Nacid tab, Setoral, Sibutil, and many more.
70GF Score
Get the complete analysis for ROCO:4173
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4173 has been successfully added to your 
